Cantor Fitzgerald Forecasts Immunovant FY2027 Earnings
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2027 earnings per share estimates for shares of Immunovant in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal expects that the company will earn ($3.26) per share for the year. Cantor Fitzgerald has a “Strong-Buy” rating […]
